Article Information
History
- September 24, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Sudhir Kshirsagar1,
- Neha Sawant1,
- Hallie Morton1,
- Arubala P. Reddy2 and
- P. Hemachandra Reddy1,3,4,5,6,*
- 1Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA
- 2Nutritional Sciences Department, College of Human Sciences, Texas Tech University, 1301 Akron Ave, Lubbock TX 79409, USA
- 3Department of Pharmacology and Neuroscience, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA
- 4Department of Neurology, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA
- 5Department of Public Health, Graduate School of Biomedical Sciences, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA
- 6Department of Speech, Language, and Hearing Sciences, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA
- ↵*Corresponding Author
P. Hemachandra Reddy, Ph.D., Department of Internal Medicine, Texas Tech University Health Sciences Center, 3601 4th Street, Lubbock TX 79430, United States, Lubbock, TX 79430, USA, Email: Hemachandra.reddy{at}ttuhsc.edu, Tel.: +1□806□743□3194
Posted September 24, 2021.
Mitophagy enhancers against phosphorylated Tau-induced mitochondrial and synaptic toxicities in Alzheimer disease
